Channel Growth ExsoMed's focus on minimally invasive extremity implants and recent regulatory clearance make it a good candidate for distribution partnerships with hospital systems and specialty distributors. A lean team can scale through channel partners to expand reach beyond its base in California and accelerate adoption in ORs.

Training Advantage The Mobile Training and Cadaver Lab program signals a strong service-led differentiator. Market opportunities exist to package education and hands-on workshops with product purchases, driving surgeon confidence, faster uptake, and potential premium pricing for training bundles.

Product Adoption FDA clearance for the NanoPhix cannulated lag screw system expands addressable procedures to common fragment fractures such as avulsion, mallet, and condylar injuries. Target trauma and hand surgery teams, emphasizing efficiency gains and outcomes to justify new adoption.

Niche Positioning ExsoMed's specialty focus on extremity minimally invasive devices can be highlighted as a competitive advantage versus broad-scope competitors. Position as an agile partner for custom surgical solutions and rapid product iterations based on surgeon feedback.

Strategic Partnerships With modest revenue and a lean team, explore co-development, licensing, and distribution agreements with larger OEMs or academic centers. Partnerships can accelerate market penetration, training reach, and real-world data generation to support broader commercialization.